Pharma News
-
Sanofi to acquire Synthorx for $2.5 B
Pharma | News | 0 Comment | 09 Dec, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive...Read more
-
Eppendorf with new CEO dual leadership
Pharma | News | 0 Comment | 06 Dec, 2019
Hamburg, December 6, 2019 – The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Busine...Read more
-
AstraZeneca receives Chinese marketing nod for Lynparza
Pharma | News | 0 Comment | 09 Dec, 2019
AstraZeneca and MSD have announced that the companies have received marketing authorisation from China’s National Medical Products Administration (NMPA) for Lynparza (o...Read more
-
Pharma | News | 0 Comment | 05 Dec, 2019
Taiwan- 5 Dec 2019 The Healthcare+ Expo Taiwan greatly appreciated by Exhibitors & Attendees for gaining pathways to Taiwan and the world . 600 Exhi...Read more
-
Strides Singapore gets USFDA tentative nod for pain relieving drug
Pharma | News | 0 Comment | 05 Dec, 2019
Strides Pharma Science Limited (Strides) has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received tentative approval for Diclo...Read more
-
Pharmapack announces key themes for Pharmapack Europe 2020
Pharma | News | 0 Comment | 04 Dec, 2019
Paris, 03 December 2019: Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapacke...Read more
-
RAPT Therapeutics collaborates with Hanmi Pharma
Pharma | News | 0 Comment | 04 Dec, 2019
US based RAPT Therapeutics, a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patient...Read more
-
Dong-A ST with Beactica to develop new cancer treatments
Pharma | News | 0 Comment | 05 Dec, 2019
Dong-A ST Co., Ltd., a Korean pharmaceutical company, and Beactica Therapeutics AB, a Swedish drug discovery company, have announced that a lead compound meeting certain pre-defined criteri...Read more
-
China NMPA accepts Lenvima for Additional Indication of Thyroid Cancer
Pharma | News | 0 Comment | 04 Dec, 2019
Tokyo based Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Produ...Read more
-
Singapore approves new early breast cancer drug
Pharma | News | 0 Comment | 03 Dec, 2019
A new breast cancer drug shown to significantly reduce the risk of cancer recurrence has received approval in Singapore – at least six months ahead of its expected...Read more
-
CMAB, Fapon join hands for biologic oncology asset
Pharma | News | 0 Comment | 03 Dec, 2019
CMAB Biopharma Inc., a pure-play, biologics contract manufacturing and development organization (CDMO) and Shenzhen Fapon Biopharma Inc., an innovative biopharmaceutical company, announced ...Read more
-
Astellas to acquire Audentes Therapeutics in a $3B deal
Pharma | News | 0 Comment | 03 Dec, 2019
Japan headquartered Astellas Pharma Inc. and Audentes Therapeutics, Inc. have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, ...Read more
-
Ascletis gets pharmaceutical trade license and GSP certificate
Pharma | News | 0 Comment | 02 Dec, 2019
Ascletis Pharma, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseas...Read more
-
Chugai to sell stake to JW Pharma for JV in Korea
Pharma | News | 0 Comment | 02 Dec, 2019
Japanese firm Chugai Pharmaceutical Co., Ltd. and Korea based JW Pharmaceutical Corporation have agreed to change the equity structure of C&C Research Laboratories (...Read more
-
Chi-Med’s Elunate enters National Reimbursement Drug List
Pharma | News | 0 Comment | 02 Dec, 2019
Hutchison China MediTech Limited (Chi-Med) has announced that Elunate® (fruquintinib capsules), its national class 1 targeted anticancer drug for the treatment of patients with adv...Read more
-
Now Innovent and Lilly’s Tyvyt included in NRDL
Pharma | News | 0 Comment | 29 Nov, 2019
Innovent Biologics, Inc. ("Innovent") a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic an...Read more
-
Ono Pharma seeks Japanese approval for tirabrutinib
Pharma | News | 0 Comment | 28 Nov, 2019
Japan based Ono Pharmaceutical Co., Ltd. has announced that ONO submitted an application of tirabrutinib hydrochloride (ONO-4059) (“Tirabrutinib”), a Bruton’s tyrosine kin...Read more
-
ONO Submits Supplemental Application for additional Opdivo®
Pharma | News | 0 Comment | 28 Nov, 2019
Intravenous Infusion Monotherapy Dosage and Schedule in Japan Ono Pharmaceutical Co., Ltd. has announced that ONO submitted a supplemental application for a partial change in the approved i...Read more
